Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bendamustine vs Chlorambucil in Untreated CLL
CTR20131457Phase 2Active
- Sponsor
- Hangzhou Rongli Pharmaceutical Technology
- Start
- Nov 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of bendamustine in chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL), sponsored by Hangzhou Rongli Pharmaceutical Technology. Started Nov 2013; status: active.
02
Drugs
bendamustine
03
Conditions
chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL)
Beyond the preview
Go deeper on CTR20131457.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20131457.